Skip to main content
. 2003 Jan 11;326(7380):84. doi: 10.1136/bmj.326.7380.84

Table 2.

 Number (percentage) of participants with appropriate secondary prevention at baseline, one year, and four years

BaselineNo (%)
One year
Four years
No (%)
Adjusted odds ratio* (95% CI)
No (%)
Adjusted odds ratio* (95% CI)
Aspirin management:
 Intervention 457/660 (69.2) 466/575 (81.0) 3.22 (2.15 to 4.80) 396/486 (81.5) 1.02 (0.71 to 1.47)
 Control 413/659 (62.7) 373/562 (66.4) 1 348/446 (78.0) 1
Blood pressure management:
 Intervention 585/673 (87.0) 572/593 (96.5) 5.32 (3.01 to 9.41) 530/564 (94.0) 1.48 (0.91 to 2.42)
 Control 583/670 (87.0) 510/580 (88.0) 1 492/534 (92.1) 1
Lipid management:
 Intervention  78/673 (11.6) 244/593 (41.1) 3.19 (2.39 to 4.26) 325/564 (57.6) 1.22 (0.93 to 1.58)
 Control  90/670 (13.4) 125/580 (21.6) 1 284/534 (53.2) 1
Moderate exercise:
 Intervention 241/663 (36.3) 247/587 (42.1) 1.67 (1.23 to 2.26) 171/494 (34.6) 1.26 (0.88 to 1.81)
 Control 204/664 (30.7) 177/568 (31.2) 1 128/455 (28.1) 1
Low fat diet:
 Intervention 287/597 (48.1) 271/480 (56.5) 1.47 (1.10 to 1.96) 308/464 (66.4) 0.74 (0.53 to 1.02)
 Control 299/616 (48.5) 226/465 (48.6) 1 301/440 (68.4) 1
Non-smoking:
 Intervention 545/668 (81.6) 483/584 (82.7) 0.78 (0.47 to 1.28) 422/491 (86.0) 0.73 (0.40 to 1.34)
 Control 543/666 (81.5) 481/568 (84.7) 1 398/454 (87.7) 1
*

Adjusted for age, sex, baseline performance and general practice.